Literature DB >> 2069380

Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi.

K Lazardi1, J A Urbina, W de Souza.   

Abstract

The ultrastructural alterations induced in vitro by ICI 195,739, a recently developed bis-triazole derivative with potent antiproliferative effects on Trypanosoma (Schizotrypanum) cruzi, are reported. On epimastigotes, the triazole at its minimum growth-inhibitory concentration (0.1 microM) produced immediately (within 24 h) gross alterations in the organization of chromatin and the appearance of large electron-dense granules; at this time, many cells were binucleated, indicating a blockade in cytokinesis. At later times (120 h), mitochondrial swelling, a characteristic effect reported previously for the dioxolane-imidazole ketoconazole when the performed ergosterol pool is depleted, was the predominant effect and led to cell lysis. In amastigotes proliferating in Vero cells, the drug at 10 nM produced mitochondrial swelling, autophagic vacuoles, and massive alterations of the plasma membrane, leading to complete parasite destruction after 96 h of incubation of the infected monolayers with the drug. The results support previous conclusions that ICI 195,739 has a dual mechanism of action against T. cruzi, involving blockade of ergosterol biosynthesis and a direct effect on cell division which cannot be reversed by addition of exogenous ergosterol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069380      PMCID: PMC245088          DOI: 10.1128/AAC.35.4.736

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Concentration and time dependence of the effects of ketoconazole on growth and sterol synthesis by Trypanosoma (Schizotrypanum) cruzi epimastigotes.

Authors:  G Larralde; J Vivas; J A Urbina
Journal:  Acta Cient Venez       Date:  1988

3.  Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans.

Authors:  H van den Bossche; G Willemsens; W Cools; W F Lauwers; L Le Jeune
Journal:  Chem Biol Interact       Date:  1978-04       Impact factor: 5.192

4.  Activity of imidazoles against Leishmania tropica in human macrophage cultures.

Authors:  J D Berman
Journal:  Am J Trop Med Hyg       Date:  1981-05       Impact factor: 2.345

5.  Mechanisms of action of the antimycotic imidazoles.

Authors:  I J Sud; D S Feingold
Journal:  J Invest Dermatol       Date:  1981-06       Impact factor: 8.551

6.  Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages.

Authors:  D T Hart; W J Lauwers; G Willemsens; H Vanden Bossche; F R Opperdoes
Journal:  Mol Biochem Parasitol       Date:  1989-03-01       Impact factor: 1.759

7.  Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent.

Authors:  J Heeres; L J Backx; J H Mostmans; J Van Cutsem
Journal:  J Med Chem       Date:  1979-08       Impact factor: 7.446

8.  The functional importance of structural features of ergosterol in yeast.

Authors:  W R Nes; B C Sekula; W D Nes; J H Adler
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

9.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.

Authors:  H Van den Bossche; G Willemsens; W Cools; F Cornelissen; W F Lauwers; J M van Cutsem
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

10.  Biochemical and ultrastructural alterations produced by miconazole and econazole in Trypanosoma cruzi.

Authors:  R Docampo; S N Moreno; J F Turrens; A M Katzin; S M Gonzalez-Cappa; A O Stoppani
Journal:  Mol Biochem Parasitol       Date:  1981-07       Impact factor: 1.759

View more
  13 in total

1.  Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Ultrastructural alterations induced by the neolignan dihydrobenzofuranic eupomatenoid-5 on epimastigote and amastigote forms of Trypanosoma cruzi.

Authors:  Patrícia Shima Luize; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Diógenes Aparício Garcia Cortez; José Andrés Morgado-Díaz; Wanderley de Souza; Celso Vataru Nakamura
Journal:  Parasitol Res       Date:  2006-06-17       Impact factor: 2.289

3.  Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis.

Authors:  Juliany C F Rodrigues; Márcia Attias; Carlos Rodriguez; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; R Lira; G Visbal; J Bartrolí
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.

Authors:  Paulo Marcos da Matta Guedes; Julio A Urbina; Marta de Lana; Luis C C Afonso; Vanja M Veloso; Washington L Tafuri; George L L Machado-Coelho; Egler Chiari; Maria Terezinha Bahia
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.

Authors:  R A Maldonado; J Molina; G Payares; J A Urbina
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

7.  Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.

Authors:  Silvia Orenes Lorente; Juliany C F Rodrigues; Carmen Jiménez Jiménez; Miranda Joyce-Menekse; Carlos Rodrigues; Simon L Croft; Vanessa Yardley; Kate de Luca-Fradley; Luis M Ruiz-Pérez; Julio Urbina; Wanderley de Souza; Dolores González Pacanowska; Ian H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

8.  Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.

Authors:  J A Urbina; K Lazardi; E Marchan; G Visbal; T Aguirre; M M Piras; R Piras; R A Maldonado; G Payares; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.

Authors:  Juliany Cola Fernandes Rodrigues; Juan Luis Concepcion; Carlos Rodrigues; Aura Caldera; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

10.  Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.

Authors:  Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.